SCHEMBL31346403

SCHEMBL31346403

CCOC(=O)C(C)(C#N)CF

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
ALDH1A1 P00352 3/20 0.41
TSHR P16473 2/20 0.41
CYP4F2 P78329 3/20 0.37
CYP4A11 Q02928 3/20 0.37
PKM P14618 3/20 0.35
MMP8 P22894 1/20 0.35
KDM4E B2RXH2 1/20 0.34
THRB P10828 1/20 0.33
LMNA P02545 1/20 0.33
HSD17B10 Q99714 1/20 0.33
ABCB11 O95342 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
HTR2A P28223 1/20 0.33
PMP22 Q01453 1/20 0.33
PPARA Q07869 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CNR2 P34972 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20348152 0.85 MEN1 (0.47) MEN1KMT2AALDH1A1TSHRCYP4F2
SCHEMBL3248205 0.84 MEN1 (0.48) MEN1KMT2AALDH1A1TSHRCYP4F2
SCHEMBL15740584 0.82 MEN1 (0.47) MEN1KMT2AALDH1A1TSHRCYP4F2
SCHEMBL9181204 0.81 MEN1 (0.50) MEN1KMT2AALDH1A1TSHRCYP4F2
SCHEMBL24872768 0.78 MEN1 (0.43) MEN1KMT2AALDH1A1TSHRCYP4F2
SCHEMBL165754 0.78 MEN1 (0.43) MEN1KMT2AALDH1A1TSHRCYP4F2
SCHEMBL15740594 0.78 MEN1 (0.43) MEN1KMT2AALDH1A1TSHRCYP4F2
SCHEMBL11566033 0.78 MEN1 (0.66) MEN1KMT2AALDH1A1TSHRCYP4F2
SCHEMBL9406425 0.78 MEN1 (0.47) MEN1KMT2AALDH1A1TSHRCYP4F2
SCHEMBL3767338 0.77 MEN1 (0.42) MEN1KMT2AALDH1A1TSHRCYP4F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747258-A2 COMPOUNDS, COMPOSITIONS, AND METHODS Tenvie Therapeutics, Inc. (US) 2026-05-27 EP disclosed
WO-2025024329-A2 COMPOUNDS, COMPOSITIONS, AND METHODS NICO THERAPEUTICS, INC. (US) 2025-01-30 WO disclosed